Lutera
Product Images NDC 54868-6210

7 FDA label images from Physicians Total Care, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lutera (NDC 54868-6210). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton Label (6210)

Carton Label (6210)
Packaging label for Lutera 0.10/0.02 mg oral tablets distributed by Physicians Total Care, Inc. The label shows the product NDC 54868-6210 with a lot number 0000 and an expiration date of 01/60. The package appears to contain 28 tablets.*
FDA Label Image

E0e1b7e9-figure-01 (Levonorgestrel And Ethinyl Estradiol Tablets Lut 1)

E0e1b7e9-figure-01 (Levonorgestrel And Ethinyl Estradiol Tablets   Lut 1)
Chemical structure of the active ingredients Levonorgestrel and Ethinyl Estradiol as shown in the image. The diagram depicts the molecular structures with labeled atoms and bonds for both compounds side by side.*
FDA Label Image

Fig 1 Tab 1 (Levonorgestrel And Ethinyl Estradiol Tablets Lut 2)

Fig 1 Tab 1 (Levonorgestrel And Ethinyl Estradiol Tablets   Lut 2)
A figure showing mean serum concentrations of levonorgestrel and ethinyl estradiol over 80 hours in 22 subjects taking Lutera (100 mcg levonorgestrel and 20 mcg ethinyl estradiol) on days 1, 6, and 21. Accompanying the graphs is a data table summarizing pharmacokinetic parameters including Cmax, Tmax, clearance, and binding values over the 21-day dosing period for both active ingredients.*
FDA Label Image

Table 2 (Levonorgestrel And Ethinyl Estradiol Tablets Lut 3)

Table 2 (Levonorgestrel And Ethinyl Estradiol Tablets   Lut 3)
A data table titled 'Percentage of Women Experiencing an Unintended Pregnancy During the First Year of Use of a Contraceptive Method,' listing various contraceptive methods with associated failure rates for perfect use and typical use. Methods include hormonal implants, sterilization, injectable progestogen, oral contraceptives, IUDs, condoms, cervical caps, diaphragms, spermicides, abstinence, withdrawal, and no contraception, with percentages reflecting risk of unintended pregnancy.*
FDA Label Image

Table 3 (Levonorgestrel And Ethinyl Estradiol Tablets Lut 4)

Table 3 (Levonorgestrel And Ethinyl Estradiol Tablets   Lut 4)
A bar chart showing circulatory disease mortality rates per 100,000 woman years categorized by age groups, smoking status, and oral contraceptive use. The chart compares ever-users and controls among nonsmokers and smokers across four age ranges: 15-24, 25-34, 35-44, and 45 and older.*
FDA Label Image

Table 4 (Levonorgestrel And Ethinyl Estradiol Tablets Lut 5)

Table 4 (Levonorgestrel And Ethinyl Estradiol Tablets   Lut 5)
Table showing the annual number of birth-related or method-related deaths per 100,000 nonsterile women by fertility-control method and age group. Methods listed include no fertility-control methods, oral contraceptives for nonsmokers and smokers, IUD, condom, diaphragm/spermicide, and periodic abstinence, with death rates increasing notably with age for certain methods.*
FDA Label Image

Face Card (Levonorgestrel And Ethinyl Estradiol Tablets Lut 6)

Face Card (Levonorgestrel And Ethinyl Estradiol Tablets   Lut 6)
An instructional diagram for Lutera, showing a 4-row weekly blister pack layout with circles representing daily pill locations from Sunday to Saturday. Arrows indicate the order of pill intake, and the pack is labeled with the Lutera brand name and active ingredients Levonorgestrel 0.1 mg and Ethinyl Estradiol 0.02 mg.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.